China Cord Blood (CO) Misses Q4 EPS by 1c

China Cord Blood (NYSE: CO) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $26.3 million versus the consensus estimate of $25.88 million.

For earnings history and earnings-related data on China Cord Blood (CO) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
• Innovaro (INV) Misses Q2 EPS by 9c